Cambrex to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
GlobeNewswire - Tue Jul 05, 11:45AM CDT
Cambrex Corporation (NYSE:CBM) ("Cambrex"
CBM: 57.00 (+1.99)
Watch for Cambrex to Potentially Pullback After Gaining 2.28% Yesterday
Comtex SmarTrend(R) - Tue Jun 28, 3:17PM CDT
Cambrex (NYSE:CBM) traded in a range yesterday that spanned from a low of $48.86 to a high of $49.97. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $49.74 on volume of 137,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CBM: 57.00 (+1.99)
Shares of CBM Up 31.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jun 21, 1:16AM CDT
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on February 10th, 2016 at $37.28. In approximately 4 months, Cambrex has returned 31.81% as of today's recent price of $49.14.
CBM: 57.00 (+1.99)
Answerthink Announces "Go Live" at Cambrex Corporation On SAP(R) ERP and LabWare LIMS 6.0 Integration Through Integrated Web Services
BusinessWire - Tue Jun 07, 8:30AM CDT
Answerthink, a division of The Hackett Group, Inc.. (NASDAQ: HCKT) and a premier developer, provider and supporter of solutions based on SAP(R) software, today announced the successful implementation of a laboratory information management system (LIMS) solution at Cambrex Corporation's Sweden facility.
CBM: 57.00 (+1.99), HCKT: 14.30 (+0.14)
Cambrex Has Returned 35.9% Since SmarTrend Recommendation (CBM)
Comtex SmarTrend(R) - Fri Jun 03, 1:09PM CDT
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on February 10th, 2016 at $37.28. In approximately 4 months, Cambrex has returned 35.94% as of today's recent price of $50.68.
CBM: 57.00 (+1.99)
Cambrex to Present at the Jefferies 2016 Global Healthcare Conference
GlobeNewswire - Fri Jun 03, 10:00AM CDT
Cambrex Corporation (NYSE:CBM) ("Cambrex"
CBM: 57.00 (+1.99)
Cambrex Announces Closing of New $500 Million Senior Credit Facility
GlobeNewswire - Mon May 23, 5:45AM CDT
Cambrex Corporation (NYSE:CBM) ("Cambrex"
CBM: 57.00 (+1.99)
Cambrex Up 25.2% Since SmarTrend Uptrend Call (CBM)
Comtex SmarTrend(R) - Thu May 19, 1:22PM CDT
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on February 10th, 2016 at $37.28. In approximately 3 months, Cambrex has returned 25.16% as of today's recent price of $46.66.
CBM: 57.00 (+1.99)
Cambrex to Present at UBS Global Healthcare Conference
GlobeNewswire - Mon May 16, 9:55AM CDT
Cambrex Corporation (NYSE:CBM) ("Cambrex"
CBM: 57.00 (+1.99)
Cambrex Has Returned 26.8% Since SmarTrend Recommendation (CBM)
Comtex SmarTrend(R) - Thu May 12, 12:42AM CDT
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on February 10th, 2016 at $37.28. In approximately 3 months, Cambrex has returned 26.77% as of today's recent price of $47.26.
CBM: 57.00 (+1.99)
Kite Pharma (KITE) Posts Narrower-than-Expected Loss in Q1
Arpita Dutt - Zacks Investment Research - Tue May 10, 8:45AM CDT
Investors will remain focused on Kite's (KITE) progress with its pipeline.
HSKA: 43.25 (-0.25), CBM: 57.00 (+1.99), KITE: 46.96 (-0.72), AMGN: 161.96 (+1.78)
Arena's (ARNA) Q1 Loss Narrower but Revenues Fall Short
Arpita Dutt - Zacks Investment Research - Tue May 10, 7:27AM CDT
Sales of Arena's (ARNA) obesity treatment, Belviq, remain lackluster.
HSKA: 43.25 (-0.25), CBM: 57.00 (+1.99), ANIP: 55.73 (+0.35), ARNA: 1.62 (unch)
New Strong Buy Stocks for May 10th
Zacks Equity Research - Zacks Investment Research - Tue May 10, 7:12AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
BMA: 76.22 (+0.41), CBM: 57.00 (+1.99), AZPN: 42.63 (+0.73), BBY: 31.53 (+0.28), BEL: 11.32 (+1.10)
Juno (JUNO) Posts Wider Loss in Q1, Focus on Pipeline
Arpita Dutt - Zacks Investment Research - Tue May 10, 6:15AM CDT
Even though Juno's (JUNO) Q1 loss was wider-than-expected, investor focus will remain on the company's pipeline progress.
HSKA: 43.25 (-0.25), CBM: 57.00 (+1.99), JUNO: 27.79 (+0.46), CELG: 103.41 (unch)
Geron (GERN) Q1 Loss In-Line, Imetelstat Remains in Focus
Arpita Dutt - Zacks Investment Research - Fri May 06, 7:18AM CDT
While Geron's (GERN) first quarter loss was in-line with expectations, investor focus remains on imetelstat.
JNJ: 122.92 (-0.01), CBM: 57.00 (+1.99), ANIP: 55.73 (+0.35), GERN: 2.70 (-0.05)
Ligand (LGND) Tops Q1 Earnings, Revenues, Updates View
Arpita Dutt - Zacks Investment Research - Thu May 05, 8:36AM CDT
In addition to announcing first quarter results, Ligand (LGND) announced the acquisition of economic rights to several programs owned by CorMatrix.
CBM: 57.00 (+1.99), OMED: 12.94 (+0.04), LGND: 128.33 (+1.57), ANIK: 53.19 (+0.40)
Illumina (ILMN) Misses on Q1 Earnings, Lowers '16 Guidance
Zacks Equity Research - Zacks Investment Research - Wed May 04, 7:33AM CDT
Illumina Inc. (ILMN) reported adjusted earnings per share (EPS) of 71 cents in the first quarter of 2016.
CBM: 57.00 (+1.99), OMED: 12.94 (+0.04), ANIP: 55.73 (+0.35), ILMN: 148.99 (+9.35)
Cambrex posts 1Q profit
Automated Insights - Fri Apr 29, 6:40PM CDT
EAST RUTHERFORD, N.J. (AP) _ Cambrex Corp. (CBM) on Friday reported first-quarter profit of $14.6 million.
CBM: 57.00 (+1.99)